These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16872310

  • 1. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
    [Abstract] [Full Text] [Related]

  • 2. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
    Zhang WM, Xiao G, Xie D, Zhang M, Guo AL, Wen JM.
    Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
    [Abstract] [Full Text] [Related]

  • 3. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1042-6. PubMed ID: 17637219
    [Abstract] [Full Text] [Related]

  • 4. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
    Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J.
    Oncol Rep; 2009 Mar 20; 21(3):713-9. PubMed ID: 19212631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
    Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E.
    Cancer Res; 2001 Jun 15; 61(12):4671-4. PubMed ID: 11406534
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF.
    Clin Cancer Res; 2004 Oct 15; 10(20):6946-55. PubMed ID: 15501973
    [Abstract] [Full Text] [Related]

  • 10. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
    Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E.
    Int J Oncol; 2005 Jan 15; 26(1):57-63. PubMed ID: 15586225
    [Abstract] [Full Text] [Related]

  • 11. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer.
    Akcakanat A, Kanda T, Koyama Y, Watanabe M, Kimura E, Yoshida Y, Komukai S, Nakagawa S, Odani S, Fujii H, Hatakeyama K.
    Cancer Chemother Pharmacol; 2004 Jul 15; 54(1):95-100. PubMed ID: 15118836
    [Abstract] [Full Text] [Related]

  • 12. NY-ESO-1 protein expression and humoral immune responses in prostate cancer.
    Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB.
    Prostate; 2004 Jun 01; 59(4):440-7. PubMed ID: 15065093
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E.
    Anticancer Res; 2009 Dec 01; 29(12):5125-30. PubMed ID: 20044626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ.
    Cancer Res; 2003 Sep 15; 63(18):6076-83. PubMed ID: 14522938
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J.
    Clin Cancer Res; 2004 Dec 15; 10(24):8396-404. PubMed ID: 15623618
    [Abstract] [Full Text] [Related]

  • 17. NY-ESO-1 expression and immunogenicity in prostate cancer patients.
    Gati A, Lajmi N, Derouiche A, Marrakchi R, Chebil M, Benammar-Elgaaied A.
    Tunis Med; 2011 Oct 15; 89(10):779-83. PubMed ID: 22076902
    [Abstract] [Full Text] [Related]

  • 18. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J.
    Clin Cancer Res; 2005 Mar 01; 11(5):1809-14. PubMed ID: 15756003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.